Recent article on iTrack Advance. What I found the most exciting was the bit about closed angle glaucoma. This affects a large number of people, and is the primary type of glaucoma in Asia. However, unlike open angle glaucoma, treatment options are very limited. Up until now there have been no MIGS treatments for these types of patients. However, recent data shows that iTrack Advance, due to its unique mechanism of action, is incredibly effective when it comes to these patients. I've seen the data for closed angle and it seems that this device is even more effective at lowering IOP and drops for this type of glaucoma than it is for open angle (which is significant, as we all know how effective it is for open angle glaucoma). This is quite exciting as not only does it significantly increase the TAM for iTrack Advance, but it will be the only MIGS option available to these patients. This means we have the whole minimally invasive surgical market to ourselves, no competitors! Given that closed angle also tends to be associated with a higher risk of blindness, there is an added impetus for early intervention. Gaining reimbursement and FDA approval for this additional indication could therefore be an additional major near term catalyst event for the share price, which I definitely do not think the current price is valuing at all.
- Forums
- ASX - By Stock
- EYE
- Nova Eye Medical (EYE) Discussion
Nova Eye Medical (EYE) Discussion, page-2797
-
-
- There are more pages in this discussion • 391 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $54.91M |
Open | High | Low | Value | Volume |
24.0¢ | 24.0¢ | 23.5¢ | $105.9K | 449.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65505 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 6000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 65505 | 0.230 |
6 | 80500 | 0.225 |
8 | 260222 | 0.220 |
4 | 228594 | 0.215 |
6 | 68945 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 6000 | 1 |
0.250 | 50000 | 1 |
0.255 | 125000 | 2 |
0.265 | 65000 | 2 |
0.270 | 29308 | 3 |
Last trade - 15.53pm 31/07/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online